- Tether USDT invests $200 million in Blackrock Neurotech, revolutionizing neurotechnology.
- Blackrock Neurotech pioneers brain-computer interface (BCI) medical devices, aiding neurological disorder patients.
- Tether Evo, Tether’s venture capital division, focuses on groundbreaking projects at the tech-human intersection.
Tether USDT is the world’s most basic stablecoin, with a market capitalization of more than $110 billion. Tether as of late verbalized an investment of $200 million to secure a lion’s share stake in Blackrock Neurotech, a brain-computer interface (BCI) company This investment is known to have been made through Tether’s wander capital division, Tether Evo.
Through an X post on April 30, 2024, Blackrock Neurotech announced an investment of $200 million from Tether. Blackrock Neurotech is a medical technology company that develops medical devices operated by brain signals. The Blackrock Neurotech assists individuals who experience neurological disorders.
BCI innovation created by Blackrock Neurotech permits patients to function mechanical arms, control wheelchairs, send messages, surf the web, and indeed drive cars utilizing the control of their contemplations.
Meanwhile, Tether Evo is Tether’s newly formed venture capital division. Through Tether Evo, Tether plans to support projects that “redefine the boundaries of possibility at the intersection of technological innovation and human potential.”
The investment in Blackrock Neurotech is Tether Evo’s first step in supporting innovative and high-impact projects. Tether’s investment in Blackrock Neurotech is expected to accelerate the commercialization and launch of a medical solution that has already been successfully implemented in more than 40 individuals.As it were, this venture will also be utilized to extend Blackrock Neurotech’s inquiry about advancement so that it remains a major player within the BCI field in the future.
Paolo Ardoino, CEO of Tether, said the investment in Blackrock Neurotech may be a step forward toward a future where innovation not as it were complements but moreover improves human involvement. In his post on X, Tether Evo could be a characteristic step to center on humans. Through Tether Evo, the company needs to assist millions of individuals around the world who endure loss of motion, misfortune of work, and neurological clutters that prevent them from strolling, seeing, hearing, feeling, or talking. Not as it were that, they too need to center on mid-term human potential and long.
On the other hand, Tether Holdings, the company behind the world’s largest stablecoin, Tie (USDT), detailed a net benefit of $4.52 billion within the to begin with quarter of 2024. This figure is the most noteworthy net benefit record ever recorded by Tether. Not only that, Tether also unveiled its net value for the first time, which came to $11.37 billion as of March 31.
The figure could be a critical increment compared to the $7.01 billion in value recorded after December 2023, concurring with Tether’s confirmation report for the primary quarter of 2024. Most of Tether’s net benefit, approximately $1 billion, came from working benefits earned from property of US Treasuries. In the meantime, the remaining $3.52 billion came from picks up on the company’s Bitcoin (BTC) and gold positions.
As Tether USDT continues to make strategic investments and innovations like its recent venture into Blackrock Neurotech, the future shines bright for this pioneering stablecoin in the crypto industry.
Read Also
disclaimer read moreCrypto News Land, also abbreviated as "CNL", is an independent media entity - we are not affiliated with any company in the blockchain and cryptocurrency industry. We aim to provide fresh and relevant content that will help build up the crypto space since we believe in its potential to impact the world for the better. All of our news sources are credible and accurate as we know it, although we do not make any warranty as to the validity of their statements as well as their motive behind it. While we make sure to double-check the veracity of information from our sources, we do not make any assurances as to the timeliness and completeness of any information in our website as provided by our sources. Moreover, we disclaim any information on our website as investment or financial advice. We encourage all visitors to do your own research and consult with an expert in the relevant subject before making any investment or trading decision.
